NCT05799638View on ClinicalTrials.gov

Strategy, Efficacy and Safety of Medication Usage in Heart Failure Patients Who Were Intolerable to GDMT

CompletedOBSERVATIONAL
Enrollment

263

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
OTHER

Guideline-Directed Medication Treatment (GDMT)

GDMT contains ACEIs/ARBs/ARNI, β blockers, SGLT2is, MRAs. ACEI/ARB/ARNI and β blocker will gradually be titrated up to the maximum tolerable dose

Trial Locations (1)

400042

The first affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

Chongqing Medical University

OTHER